Usana Health Sciences Inc financial data

Symbol
USNA on NYSE
Location
3838 West Parkway Blvd., Salt Lake City, UT
Fiscal year end
December 28
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 248 % -32.6%
Quick Ratio 56.6 % +3.8%
Return On Equity 6.42 % -42.3%
Return On Assets 4.7 % -46.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.3M shares -4.1%
Common Stock, Shares, Outstanding 18.3M shares -4.14%
Entity Public Float 499M USD -28.6%
Common Stock, Value, Issued 18K USD -5.26%
Weighted Average Number of Shares Outstanding, Basic 18.5M shares -2.94%
Weighted Average Number of Shares Outstanding, Diluted 18.5M shares -3.25%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 899M USD +2.75%
Operating Income (Loss) 56.2M USD -33.4%
Nonoperating Income (Expense) 8.39M USD -17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 64.6M USD -31.6%
Income Tax Expense (Benefit) 29.8M USD -24.4%
Net Income (Loss) Attributable to Parent 34.1M USD -38.1%
Earnings Per Share, Basic 1 USD/shares -37.5%
Earnings Per Share, Diluted 1 USD/shares -37.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 151M USD -54.5%
Inventory, Net 83.3M USD +34.7%
Other Assets, Current 4.81M USD -21.1%
Assets, Current 262M USD -37.5%
Deferred Income Tax Assets, Net 26.4M USD +45.3%
Property, Plant and Equipment, Net 96.5M USD -1.18%
Operating Lease, Right-of-Use Asset 21.2M USD +19.8%
Intangible Assets, Net (Excluding Goodwill) 143M USD +398%
Goodwill 144M USD +757%
Other Assets, Noncurrent 62.7M USD +23%
Assets 735M USD +16.3%
Accounts Payable, Current 17.9M USD +169%
Employee-related Liabilities, Current 15.8M USD -2.24%
Accrued Liabilities, Current 13.6M USD +39.2%
Liabilities, Current 122M USD +17.1%
Deferred Income Tax Liabilities, Net 4.66M USD +0.19%
Operating Lease, Liability, Noncurrent 10.2M USD +98.2%
Other Liabilities, Noncurrent 22.7M USD +113%
Liabilities 149M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -19.3M USD +5.65%
Retained Earnings (Accumulated Deficit) 474M USD +2.19%
Stockholders' Equity Attributable to Parent 531M USD +3.68%
Liabilities and Equity 735M USD +16.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.5M USD -12.4%
Net Cash Provided by (Used in) Financing Activities -14.5M USD -21.1%
Net Cash Provided by (Used in) Investing Activities -3.88M USD +4.74%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 18.3M shares -4.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.14M USD -0.05%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 154M USD -54%
Interest Paid, Excluding Capitalized Interest, Operating Activities 52K USD +117%
Deferred Tax Assets, Valuation Allowance 157M USD +14.1%
Deferred Tax Assets, Gross 200M USD +13.3%
Operating Lease, Liability 16.2M USD +30.5%
Payments to Acquire Property, Plant, and Equipment 2.8M USD -12.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 35.3M USD -33.5%
Lessee, Operating Lease, Liability, to be Paid 17.8M USD +38.2%
Property, Plant and Equipment, Gross 212M USD +1.2%
Operating Lease, Liability, Current 6.01M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.16M USD +7.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.74M USD -11.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.62M USD +237%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.83M USD +115%
Deferred Tax Assets, Operating Loss Carryforwards 2.35M USD +20%
Unrecognized Tax Benefits 1.19M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.17M USD +1695%
Depreciation, Depletion and Amortization 7.74M USD +103%
Deferred Tax Assets, Net of Valuation Allowance 43.5M USD +10.3%
Interest Expense 283K USD +48.2%